In their application, the drugmakers cited follow-up data from a phase 3 clinical trial involving 2,228 children, which showed two doses of the vaccine were 100 percent effective against COVID-19. Thirty symptomatic COVID-19 cases occurred during the trial, but all were among the placebo group.
The FDA granted the vaccine emergency use authorization for children ages 12 to 15 in May and fully approved it for everyone 16 and up in August.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
